{"entity":{"id":"kiyatec","kind":"company","name":"Kiyatec","aka":[],"tldr":"Kiyatec grows a patient's tumour cells in 3D culture and tests drugs on them, with a focus on ovarian, breast, glioblastoma and rare tumours.","summary":"Kiyatec's ex vivo 3D cell culture platform predicts which drugs a patient's tumour will respond to by exposing living tumour cells to candidate therapies, and it has published clinical correlation studies in glioblastoma and ovarian cancer. Physician-ordered.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://kiyatec.com/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["ctgov-sponsor","fcct-directory"],"related":[],"cancers":["ovarian","glioblastoma","breast-hr-positive"],"sections":[],"technologies":["functional-drug-testing","organoids"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"United States (city not published)","country":"US","companyType":"diagnostics","website":"https://kiyatec.com/","investors":[],"funding":[]},"route":"/companies/kiyatec/","neighbours":{"cancer":[{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"technology":[{"id":"functional-drug-testing","kind":"technology","name":"Functional (ex vivo) drug testing","route":"/technologies/functional-drug-testing/"},{"id":"organoids","kind":"technology","name":"Patient-derived organoids","route":"/technologies/organoids/"}]}}